Gastrointestinal Tract Tumours: Essentials for Clinicians is the latest edition of the very popular ESMO Essentials for Clinicians series.
Gastrointestinal (GI) tumours have a significant incidence in Europe and are among the most frequent tumours to be diagnosed globally.
The ESMO Publishing Working Group therefore decided that GI tract tumours should be the next topic to be addressed in this series of educational books.
The Essentials for Clinicians publications are intended primarily to be read by young oncologists (residents at the beginning of their career) by providing the reader with the essential information in a visual and informative way.
The series follows a distinct format that enables the reader to easily assimilate the information and then test their knowledge by answering the revision questions at the end of each page. The second section of this publication allows the reader to build on this essential knowledge, focussing on more advanced topics.
This next edition of ESMO’s Essentials for Clinicians focuses firmly on Gastrointestinal (GI) Tract Tumours. In line with publications past, it has primarily been devised as a “must-have” educational tool to serve and guide oncologists-in-training – the future of our profession.
By providing a comprehensive update on some of the very latest discoveries within the GI field, spanning a wide range of gastrointestinal malignancies and, indeed, various perspectives, it will also be of general appeal to colleagues and oncoprofessionals working across other specialities.
Organised into two main sections: “What every oncologist should know” and “More advanced knowledge”, this book includes excellent contributions from internationally renowned leaders in oncology, tackling the “everything you need to know” from the expanding understanding of the molecular basis of GI cancers, the diagnosis, staging, tracking of response, and interventional radiology of GI tumours, to the latest updates from leading physician–scientists in oesophageal, gastric, colon, rectal, pancreatic and hereditary colorectal cancer.
The second section covers essential developments exploring epidemiological factors implicated in GI cancer, disease prevention, the new opportunities that promise to advance our understanding, molecular subtyping, and tailored treatment of these diseases, as well as an “under the lens” look at rarer GI tumours.
Importantly, we are now in an era of precision medicine against cancer, driven by the multidisciplinary approach to cancer science, treatment and care, and resources aimed at crucially “lightening the load” for clinicians.
Therefore, medical oncologists, researchers and other cancer specialists and professionals should seek to report and exchange expertise on a wide range of topics from different perspectives across tumour types.
It is thanks to the superb co-editorship of Professor Andrés Cervantes and Dr Henk van Halteren that ESMO’s Gastrointestinal Tract Tumours: Essentials for Clinicians has most certainly delivered on this ambition.
Josep Tabernero, MD, PhD